"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...

The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — ...

The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

An expert discusses how treatment decisions in metastatic castration-resistant prostate cancer (mCRPC) increasingly depend on prior androgen receptor pathway inhibitor (ARPI) exposure, highlighting ...

Cancer cannot be understood as a single, uniform disease. The more we delve into studying each type of tumor, the more we ...

Dilbert' cartoonist Scott Adams has metastatic prostate cancer similar to what President Biden just announced. He alluded to using California aid-in-dying law.

The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic ...

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

Adding niraparib to abiraterone acetate and prednisone may help slow cancer growth for patients with metastatic ...

The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...

Darolutamide is now an FDA-approved treatment option alone or in combination with docetaxel for metastatic ...

Former President Joe Biden has been diagnosed with metastatic prostate cancer at age 82. Here's what to know about the ...